Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view
Ali Najmeddin, Mina Bahrololoumi Shapourabadi, Mahdi Behdani, Farid Abedin Dorkoosh
Topics & Concepts
Coronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakIntensive care medicineDiseaseInfectious disease (medical specialty)VirologyPathologyOutbreakSARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responses